Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,191 INR | -2.58% | +0.37% | +10.50% |
May. 15 | India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment | RE |
May. 15 | India's weight in key MSCI equity index hits another high, to boost inflows | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.50% | 10.79B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- MANKIND Stock
- News Mankind Pharma Limited
- Jefferies Adjusts Mankind Pharma's Price Target to INR1,870 From INR1,830, Keeps at Hold